BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12699766)

  • 21. The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.
    Hansen HH; Andreasen JT; Weikop P; Mirza N; Scheel-Krüger J; Mikkelsen JD
    Eur J Pharmacol; 2007 Sep; 570(1-3):77-88. PubMed ID: 17628530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered neurotensin mrna expression in mice lacking the dopamine transporter.
    Roubert C; Spielewoy C; Soubrié P; Hamon M; Giros B; Betancur C
    Neuroscience; 2004; 123(2):537-46. PubMed ID: 14698760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.
    Lin JS; Hou Y; Jouvet M
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14128-33. PubMed ID: 8943072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala.
    Day HE; Badiani A; Uslaner JM; Oates MM; Vittoz NM; Robinson TE; Watson SJ; Akil H
    J Neurosci; 2001 Jan; 21(2):732-40. PubMed ID: 11160452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.
    Leo D; Sukhanov I; Zoratto F; Illiano P; Caffino L; Sanna F; Messa G; Emanuele M; Esposito A; Dorofeikova M; Budygin EA; Mus L; Efimova EV; Niello M; Espinoza S; Sotnikova TD; Hoener MC; Laviola G; Fumagalli F; Adriani W; Gainetdinov RR
    J Neurosci; 2018 Feb; 38(8):1959-1972. PubMed ID: 29348190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cocaine- and amphetamine-regulated transcript (CART) peptides modulate the locomotor and motivational properties of psychostimulants.
    Couceyro PR; Evans C; McKinzie A; Mitchell D; Dube M; Hagshenas L; White FJ; Douglass J; Richards WG; Bannon AW
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1091-100. PubMed ID: 16099925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forebrain projections from cholecystokininlike-immunoreactive neurons in the rat midbrain.
    Seroogy KB; Fallon JH
    J Comp Neurol; 1989 Jan; 279(3):415-35. PubMed ID: 2918078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine.
    Izenwasser S; Coy AE; Ladenheim B; Loeloff RJ; Cadet JL; French D
    Eur J Pharmacol; 1999 Jun; 373(2-3):187-93. PubMed ID: 10414438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice.
    Beaulieu JM; Sotnikova TD; Gainetdinov RR; Caron MG
    J Biol Chem; 2006 Oct; 281(43):32072-80. PubMed ID: 16954211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ProSAAS-derived peptides are regulated by cocaine and are required for sensitization to the locomotor effects of cocaine.
    Berezniuk I; Rodriguiz RM; Zee ML; Marcus DJ; Pintar J; Morgan DJ; Wetsel WC; Fricker LD
    J Neurochem; 2017 Nov; 143(3):268-281. PubMed ID: 28881029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.
    Mannangatti P; Ragu Varman D; Ramamoorthy S; Jayanthi LD
    Pharmacology; 2021; 106(11-12):597-605. PubMed ID: 34515205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations.
    Calipari ES; Ferris MJ; Melchior JR; Bermejo K; Salahpour A; Roberts DC; Jones SR
    Addict Biol; 2014 Mar; 19(2):145-55. PubMed ID: 22458761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
    Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
    J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
    Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
    J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.
    Gross JD; Kaski SW; Schroer AB; Wix KA; Siderovski DP; Setola V
    J Psychopharmacol; 2018 Feb; 32(2):191-203. PubMed ID: 29364035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms.
    Dela Peña I; Gevorkiana R; Shi WX
    Eur J Pharmacol; 2015 Oct; 764():562-570. PubMed ID: 26209364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dopamine transporter and attention-deficit/hyperactivity disorder.
    Madras BK; Miller GM; Fischman AJ
    Biol Psychiatry; 2005 Jun; 57(11):1397-409. PubMed ID: 15950014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.
    Mergy MA; Gowrishankar R; Davis GL; Jessen TN; Wright J; Stanwood GD; Hahn MK; Blakely RD
    Neurochem Int; 2014 Jul; 73():56-70. PubMed ID: 24332984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.